Shimada K - Search Results

1

Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells.

Ito T, Ikeda U, Yamamoto K, Shimada K. Ito T, et al. Among authors: shimada k. Atherosclerosis. 2002 Nov;165(1):51-5. doi: 10.1016/s0021-9150(02)00194-6. Atherosclerosis. 2002. PMID: 12208470

2

Fluvastatin enhances apoptosis in cytokine-stimulated vascular smooth muscle cells.

Takahashi M, Ogata Y, Okazaki H, Takeuchi K, Kobayashi E, Ikeda U, Shimada K. Takahashi M, et al. Among authors: shimada k. J Cardiovasc Pharmacol. 2002 Feb;39(2):310-7. doi: 10.1097/00005344-200202000-00018. J Cardiovasc Pharmacol. 2002. PMID: 11791017

3

Matrix metalloproteinase expression in the coronary circulation induced by coronary angioplasty.

Hojo Y, Ikeda U, Katsuki Ta, Mizuno O, Fujikawa H, Shimada K. Hojo Y, et al. Among authors: shimada k. Atherosclerosis. 2002 Mar;161(1):185-92. doi: 10.1016/s0021-9150(01)00615-3. Atherosclerosis. 2002. PMID: 11882331

4

Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism.

Takahashi M, Okazaki H, Ogata Y, Takeuchi K, Ikeda U, Shimada K. Takahashi M, et al. Among authors: shimada k. Atherosclerosis. 2002 Apr;161(2):387-94. doi: 10.1016/s0021-9150(01)00674-8. Atherosclerosis. 2002. PMID: 11888522

5

Increased levels of monocyte-related cytokines in patients with unstable angina.

Hojo Y, Ikeda U, Takahashi M, Shimada K. Hojo Y, et al. Among authors: shimada k. Atherosclerosis. 2002 Apr;161(2):403-8. doi: 10.1016/s0021-9150(01)00636-0. Atherosclerosis. 2002. PMID: 11888524

6

beta-very low density lipoprotein enhances inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells.

Takahashi M, Takahashi S, Shimpo M, Naito A, Ogata Y, Kobayashi E, Ikeda U, Shimada K. Takahashi M, et al. Among authors: shimada k. Atherosclerosis. 2002 Jun;162(2):307-13. doi: 10.1016/s0021-9150(01)00727-4. Atherosclerosis. 2002. PMID: 11996950

7

HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells.

Ito T, Ikeda U, Shimpo M, Ohki R, Takahashi M, Yamamoto K, Shimada K. Ito T, et al. Among authors: shimada k. Cardiovasc Drugs Ther. 2002 Mar;16(2):121-6. doi: 10.1023/a:1015701415588. Cardiovasc Drugs Ther. 2002. PMID: 12090904

8

An anti-ulcer drug, geranylgeranylacetone, suppresses inducible nitric oxide synthase in cultured vascular smooth muscle cells.

Yamamoto K, Sarukawa M, Ito T, Aoki H, Ichida M, Shimada K. Yamamoto K, et al. Among authors: shimada k. J Hypertens. 2005 Oct;23(10):1847-53. doi: 10.1097/01.hjh.0000182525.74934.c0. J Hypertens. 2005. PMID: 16148608

9

Identification of mechanically induced genes in human monocytic cells by DNA microarrays.

Ohki R, Yamamoto K, Mano H, Lee RT, Ikeda U, Shimada K. Ohki R, et al. Among authors: shimada k. J Hypertens. 2002 Apr;20(4):685-91. doi: 10.1097/00004872-200204000-00026. J Hypertens. 2002. PMID: 11910304

10

Monocyte chemoattractant protein-1 and coronary artery disease.

Ikeda U, Matsui K, Murakami Y, Shimada K. Ikeda U, et al. Among authors: shimada k. Clin Cardiol. 2002 Apr;25(4):143-7. doi: 10.1002/clc.4960250403. Clin Cardiol. 2002. PMID: 12000070 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,722 results

Search Page

Filters